| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | 0.048 | 0.2 |
| mRNA | skepinone-L | CTRPv2 | pan-cancer | AAC | -0.073 | 0.2 |
| mRNA | XMD8-85 | GDSC1000 | pan-cancer | AAC | -0.078 | 0.2 |
| mRNA | WZ-1-84 | GDSC1000 | pan-cancer | AAC | -0.077 | 0.2 |
| mRNA | GSK269962A | GDSC1000 | pan-cancer | AAC | -0.047 | 0.2 |
| mRNA | Bortezomib | CTRPv2 | pan-cancer | AAC | 0.05 | 0.2 |
| mRNA | BRD8958 | CTRPv2 | pan-cancer | AAC | -0.056 | 0.2 |
| mRNA | Irinotecan | FIMM | pan-cancer | AAC | -0.16 | 0.2 |
| mRNA | BRD1835 | CTRPv2 | pan-cancer | AAC | -0.053 | 0.2 |
| mRNA | BRD-K14844214 | CTRPv2 | pan-cancer | AAC | -0.055 | 0.2 |